New chiral methyloxyiminomethyl (MOIM) β-adrenergic antagonists. (S)- and (R)-N-[3-(alkylamino)-2-hydroxypropylidene](p-chlorophenylmethyloxy)amines as probes for determining enantiomeric specificity in the class of MOIM-type β-adrenergic blocking agents

European Journal of Medicinal Chemistry

Volumn 31, Issue 3, 1996, Pages 199-206

  Balsamo, A ^a   Breschi, M C ^a   Chiellini, G ^a   Macchia, B ^a   Macchia, M ^a   Manera, C ^a   Sacca P ^a   Scatizzi, R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adrenergic drug; Chiral N 3 (alkylamino) 2 hydroxypropylidene (p chlorophenylmethyloxy)amine; blocking agent

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICHLORISOPRENALINE; N [3 (ISOPROPYLAMINO) 2 HYDROXYPROPYLIDENE](4 CHLOROPHENYLMETHOXY)AMINE; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CATTLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; GUINEA PIG; HEART ATRIUM; IN VITRO STUDY; LUNG; NONHUMAN; RAT; REACTION ANALYSIS; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; TRACHEA;

EID: 0029918789     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/0223-5234(96)89135-5     Document Type: Article

References (30)

1. Ammon HL, Balsamo A, Macchia B, Macchia F, Howe DB, Keefe WE (1975) Experientia 31, 644-645
2. Ammon HL, Howe DB, Erhardt WD et al (1977) Acta Cryst B33, 21-29
3. Petrongolo C, Macchia B, Macchia F, Martinelli A (1977) J Med Chem 20, 1645-1653
4. Macchia B, Macchia F, Martinelli A (1980) Eur J Med Chem 15, 515-520
5. Macchia B, Macchia F, Martinelli A (1983) Eur J Med Chem 18, 85-90
6. Main BG (1990) Comprehensive Medicinal Chemistry. Pergamon Press, Oxford, 3, 187-227
7. Ruffolo RR Jr (1991) Tetrahedron 47, 9953-9980
8. Leclerc G, Amlaiky N, Rouot B (1982) Eur J Med Chem 17, 69-74
9. Easson LH, Stedman E (1933) Biochem J 27, 1257-1266
10. Leclerc G, Bieth N, Schwartz J (1980) J Med Chem 23, 620-624
11. Bouzoubaa M, Leclerc G, Decker N, Schwartz J, Andermann G (1984) J Med Chem 27, 1291-1294
12. Macchia B, Balsamo A, Lapucci A et al (1985) J Med Chem 28, 153-160
13. Balsamo A, Gentili D, Lapucci A, Macchia M, Martinelli A, Orlandini E (1994) Il Farmaco 49, 759-766
14. Imbs JL, Miesch F, Schwartz J et al (1977) Br J Pharmacol 60, 357-362
15. Leclerc G, Mann A, Wermuth CG, Bieth N, Schwartz J (1977) J Med Chem 20, 1657-1662
16. Gentili D, Lapucci A, Macchia B et al (1995) Il Farmaco 50, 519-526
17. Baldwin JJ, McClure DE, Gross DM, Williams M (1982) J Med Chem 25, 931-936
18. Bouzoubaa M, Leclerc G, Rakhit S, Andermann G (1985) J Med Chem 28, 896-900
19. Macchia B, Balsamo A, Breschi MC et al (1994) J Med Chem 37, 1518-1525
20. Balsamo A, Breschi MC, Chiellini G et al (1995) Eur J Med Chem 30, 743-755
21. Jung ME, Shaw TJ (1980) J Am Chem Soc 102, 6304-6311
22. Danklmaier J, Honig H (1988) Liebigs Ann Chem 1149-1153
23. Balsamo A, Belfiore MS, Macchia M et al (1994) Eur J Med Chem 29, 787-794
24. Rosenberg S, Silver SM, Sayer JM, Jencks WP (1974) J Am Chem Soc 7986-7998
25. Karabatsos GJ, Hsi N (1967) Tetrahedron 23, 1079-1095
26. Dooley DJ, Bittiger H, Reymann NC (1986) Eur J Pharmacol 130, 137-139
27. Nahorski SR, Richardson A (1979) Br J Pharmacol 66, 469-470
28. Minneman K, Hegstrand LR, Molinoff PB (1979) Mol Pharmacol 16, 34-46
29. Howe R, Shanks RG (1966) Nature (Lond) 210, 1336-1338
30. Hernauder M, Prieto D, Simonsen V, Rivera L, Barabona MV, Garcia S (1992) Br J Pharmacol 107, 924-931